טוען...

Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy

BACKGROUND: High dose intravenous proton pump inhibitor after endoscopic therapy for peptic ulcer bleeding has been recommended as adjuvant therapy. Whether oral proton pump inhibitor can replace intravenous proton pump inhibitor in this setting is unknown. This study aims to compare the clinical ef...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Yen, Hsu-Heng, Yang, Chia-Wei, Su, Wei-Wen, Soon, Maw-Soan, Wu, Shun-Sheng, Lin, Hwai-Jeng
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2012
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3503825/
https://ncbi.nlm.nih.gov/pubmed/22681960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-230X-12-66
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!